- Home
- AUTL vs NEWT Comparison
AUTL vs NEWT Comparison
Compare AUTL & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.48
Company Overview
Basic Information| Metric | AUTL | NEWT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 395.5M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | NEWT |
|---|---|---|
| Price | $1.48 | $12.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.50 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 1.7M | 223.6K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $84.74 | N/A |
| Revenue Next Year | $65.76 | $12.45 |
| P/E Ratio | ★ N/A | $5.99 |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.15 | $9.51 |
| 52 Week High | $2.70 | $14.91 |
Technical Indicators
Market Signals| Indicator | AUTL | NEWT |
|---|---|---|
| Relative Strength Index (RSI) | 54.72 | 62.38 |
| Support Level | $1.45 | $11.24 |
| Resistance Level | $1.52 | $14.91 |
| Average True Range (ATR) | 0.08 | 0.37 |
| MACD | 0.02 | 0.21 |
| Stochastic Oscillator | 80.25 | 99.77 |
Price Performance
Historical Comparison AUTL
NEWT
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.